Di Bleximo corp.

Circa la società

Bleximo is building a new type of computing system called “quantum accelerators”, working in conjunction with conventional powerful computers and tackling problems which are impractical or even impossible to solve on conventional digital computers alone. These accelerators leverage the laws of quantum physics and are designed for particular problems in specific industries. The company's initial focus is on providing quantum accelerators for simulating the structure and properties of molecules and chemical reactions. By modeling the behavior of certain molecules, Bleximo aims to help optimize drug discovery and drug design for pharmaceutical applications. Bleximo was established in 2017 and is based in Berkeley, California.